We are committed to providing the best healthcare services tailored to your needs. With a team of experienced medical professionals and state-of-the-art technology,
A Big Leap Forward in PAH Care Pahr Therapeutics Inc. has raised $14 million in seed funding to accelerate its mission of developing cutting-edge therapies for pulmonary arterial hypertension (PAH) a rare, progressive disease that affects the lung...
Read Full Report ⟶Reimagining Immunology, Together In a groundbreaking partnership, Bristol Myers Squibb (BMS) and Bain Capital have come together to launch a new, independent biopharmaceutical company focused entirely on developing next-generation treatments for a...
Read Full Report ⟶Genethon, a global leader in gene therapy for rare genetic diseases, has received the green light from the UK and France’s top regulatory bodies EMA and MHRA to begin phase 3 clinical trials for its experimental gene therapy, GNT0004, targeting Duc...
Read Full Report ⟶The global nephrology devices market is experiencing steady expansion, fueled by a rising prevalence of kidney-related disorders such as chronic kidney disease (CKD) and end-stage renal disease (ESRD). The market is valued at USD 15.37 billion in 202...
Read Full Report ⟶The global neurology devices market was valued at USD 15.98 billion in 2024, grew to USD 17.28 billion in 2025, and is expected to reach USD 34.76 billion by 2034. This reflects a strong CAGR of 8.14% from 2025 to 2034. The rising prevalence of cent...
Read Full Report ⟶We are committed to providing the best healthcare services tailored to your needs We are committed to providing the best healthcare services tailored
